Comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Eicosapentaenoic acid (Primary) ; Pitavastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacodynamics
- 01 Aug 2018 Status changed from active, no longer recruiting to completed.
- 01 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 28 Jan 2011 New trial record